Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Pilot of a perinatal palliative care program for parents facing severe fetal or early neonatal diagnoses

Official title: Testing a Perinatal Palliative Care Intervention Program Within Standard Perinatal Healthcare: Pilot Testing Protocol

Run by Vrije Universiteit Brussel · NCT06456034 · Data updated 2026-11-12

This pilot will test a perinatal palliative care program to support parents in Flanders who receive a severe fetal or early neonatal diagnosis.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorVrije Universiteit Brussel
Academic / other
Locations2 sites (Brussels and 1 other locations)
StatusRecruiting
StartedMay 18, 2025
Main results expectedDecember 2025
Study endsDecember 2025
Registry record updatedSeptember 22, 2025
Trial IDNCT06456034 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are parents over 18 who receive a severe fetal diagnosis after 20 weeks and decide to continue or terminate the pregnancy resulting in stillbirth, or parents of infants with a severe neonatal diagnosis within the first week, who speak Dutch or can participate with an interpreter and are deemed emotionally approachable by clinicians.

Probably not a fit

Patients under 18, those with a documented psychiatric disorder prior to the diagnosis, those judged not emotionally approachable by the treating team, or families outside the specified timeframe or geographic catchment are unlikely to benefit from this pilot.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The program implements a coordinated perinatal palliative care pathway adapted to the Flemish context, offering clinical support to parents and training/support to healthcare providers. It enrolls parents who receive a severe fetal diagnosis after 20 weeks and either continue the pregnancy or undergo termination resulting in stillbirth, as well as parents of live-born infants with a severe neonatal diagnosis in the first week. Feasibility and preliminary effectiveness will be measured by comparing parental, clinical, and provider outcomes to baseline measurements collected on the same hospital wards before implementation. Outcome domains include parental wellbeing, decision-making support, bereavement outcomes, and provider acceptability and feasibility metrics.

Why it matters

Potential benefit: If successful, the program could improve emotional support, decision support, and bereavement care for affected families while strengthening provider confidence in perinatal palliative practices.

How similar studies have gone: Perinatal palliative care programs have been described and associated with improved family satisfaction and bereavement support, but rigorous comparative trials are limited and context-specific implementation data remain scarce.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Parents:

  * who receive a severe foetal diagnosis for their unborn child and decide to continue the pregnancy after 20 weeks of gestation , or
  * who receive a severe foetal diagnosis for their unborn child after 20 weeks gestation and decide to terminate the pregnancy (with or without feticide) resulting in the stillbirth of their child
* Parents who receive a severe neonatal diagnosis for their live-born infant in the first week after birth

Additional inclusion criteria for parents:

* Parents are either Dutch speaking, or are willing to participate with support from a (phone or real life) interpreter, in collaboration with the "Agentschap Integratie \& Inburgering"
* Parents are older than 18
* Parents are not suffering from an officially diagnosed psychiatric disorder prior to receiving the severe diagnosis of their child
* Parents are deemed (emotionally) approachable for the current study by the treating physician

For each family included in the pilot study, the physicians and nurses/midwives who will be/are most closely involved in the care of the infant and the parents will also be asked to participate. If healthcare providers refuse to provide informed consent to participate in the study, their data will be deemed as missing for that case (parental outcomes are considered as the primary outcome measures).

Where it's running

  • UZ Brussels
    Brussels, Belgium
    Recruiting
  • UZ Gent
    Ghent, Belgium
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.